IL-10: a tacrolimus-specific cytotoxic mediator in ongoing allograft rejection.
Fujisawa Research Institute of America, Evanston, Illinois, USA.
H
H
Jiang
X F
XF
Yang
C
C
Wynn
R
R
Soriano
K
K
Krishnan
T
T
Fujimura
M
M
Kobayashi
D000284:Administration, Oral; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D015496:CD4-Positive T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000187:drug effects / Q000276:immunology; D016572:Cyclosporine / Q000627:therapeutic use*; D016207:Cytokines / Q000037:antagonists & inhibitors; D004359:Drug Therapy, Combination; D006084:Graft Rejection / Q000276:immunology / Q000517:prevention & control*; D016027:Heart Transplantation / Q000276:immunology; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016753:Interleukin-10 / Q000276:immunology*; D023421:Models, Animal; D051381:Rats; D011917:Rats, Inbred Lew; D016559:Tacrolimus / Q000627:therapeutic use*; D014184:Transplantation, Homologous
D000911:Antibodies, Monoclonal; D016207:Cytokines; D007166:Immunosuppressive Agents; D016753:Interleukin-10; D016572:Cyclosporine; D016559:Tacrolimus